Company Overview

Pathwork Diagnostics, Inc. develops genomics-based/molecular diagnostics for oncology applications. It offers Pathwork Tissue of Origin Test, a microarray-based gene expression test that uses a tumor's own genomic information to help pathologists and oncologists in the diagnosis of cancer cases, including poorly differentiated, undifferentiated, and metastic cancer. The company’s Tissue of Origin Testing Service aids in the identification of tumor types representing various morphologies, including bladder, breast, colorectal, gastric, hepatocellular, kidney, non-small cell lung, non-Hodgkin lymphoma, melanoma, ovarian, pancreatic, prostate, sarcoma, testicular germ cell, thyroid, endometrial...

Pathwork Diagnostics, Inc. develops genomics-based/molecular diagnostics for oncology applications. It offers Pathwork Tissue of Origin Test, a microarray-based gene expression test that uses a tumor's own genomic information to help pathologists and oncologists in the diagnosis of cancer cases, including poorly differentiated, undifferentiated, and metastic cancer. The company’s Tissue of Origin Testing Service aids in the identification of tumor types representing various morphologies, including bladder, breast, colorectal, gastric, hepatocellular, kidney, non-small cell lung, non-Hodgkin lymphoma, melanoma, ovarian, pancreatic, prostate, sarcoma, testicular germ cell, thyroid, endometrial, and head and neck. It offers its Pathwork Tissue of Origin Testing Service through its Pathwork Diagnostics Laboratory. Pathwork Diagnostics, Inc. was formerly known as Predicant Biosciences, Inc. and changed its name to Pathwork Diagnostics, Inc. in July 2006. The company was founded in 2002 and is based in Redwood City, California.

Key Executives for Pathwork Diagnostics, Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions